TL;DR
Most brands in the mushroom wellness market fail basic transparency tests. The average score across 101 audited entries is 52/100. No public COA is the most common failure. Proprietary blends are endemic. Medical claims routinely exceed what evidence supports. The FDA has issued recalls and warning letters in this category as recently as 2025.
A high transparency score does not mean a product is safe or effective. It means a consumer can find the information they need before deciding. Most brands in this audit don't clear that bar.
Audit dataset
The full 101-entry scorecard is now available as crawlable HTML plus CSV/JSON downloads: entry number, brand, category, batch, score, grade, and context. This strengthens the report as an original data asset rather than only an editorial article.
Key facts
What the audit found — in order of severity
- 1COA visibility is the sharpest dividing line. Less than 15% of audited brands link a batch-specific, accredited third-party COA directly from a product page. An on-site lab or a facility certification is not the same thing. Both scored lower than brands providing independent, batch-level, pre-purchase access.
- 2Proprietary blends are endemic. Blends with a combined total weight but no per-ingredient amounts were confirmed across functional, Amanita, and nootropic categories. A consumer cannot assess dose, species, or format from a blend total alone.
- 3Medical claims routinely exceed evidence. Disease-treatment language — "treats anxiety," "cures depression," "replaces medication" — appeared on product pages across all three categories. DSHEA permits structure/function claims only; disease claims are not permitted for dietary supplements without FDA pre-approval.
- 4Regulatory action is documented and ongoing. The FDA issued a recall affecting Diamond Shruumz products following 180+ illnesses and hospitalizations in 2024. A 2025 FDA warning letter found Blue Forest Farms Amanita products adulterated, citing risk of seizure, coma, and death. Both brands remained marketed after these actions.
- 5iMicrodosing.com scored 80/100 Grade B. Highest in the psilocybin-adjacent category. Verified batch COAs from Rose City Laboratories (ANAB/ILAC-MRA accredited), zero disease-treatment claims on commerce pages, named leadership, live support, and a best-in-audit dedicated shipping-transparency page. Gap: legal context is handled by this .net property rather than surfaced on commerce pages directly.
The 100-point framework
Ten dimensions — what each measures
COA Visibility (10 pts)
Batch-specific Certificate of Analysis accessible before purchase from a named accredited third-party lab — linked from the product page, no login or purchase required.
Lab Panel Clarity (10 pts)
Full contaminant panel visible: potency, heavy metals, microbials, pesticides, solvents. A potency-only COA scores lower than a full-panel COA regardless of lab accreditation.
Ingredient Transparency (10 pts)
Species identity, format (fruiting body vs. mycelium), extraction method, standardization — and no proprietary blends concealing per-ingredient amounts.
Dosage Clarity (10 pts)
Per-serving compound amounts, serving size, and frequency guidance stated in plain language on the product page.
Medical Claim Restraint (10 pts)
10 = zero disease-treatment claims. 0 = disease-treatment claims present. DSHEA structure/function language is acceptable; "treats," "cures," or "replaces medication" is not.
Legal Disclaimers (10 pts)
Full DSHEA disclaimer, pregnancy/lactation caution, and no unsupported jurisdictional claims ("100% legal everywhere").
Support Availability (10 pts)
Named company leadership, working phone and email, live chat or equivalent, named physical location. Anonymous contact forms score lower.
Shipping Transparency (10 pts)
Processing cutoff, named carriers, free threshold, expedited pricing, lost-order policy — on a dedicated, findable page.
Review Visibility (10 pts)
Independent third-party review footprint: Trustpilot (500+ reviews), BBB accreditation, Google Business Profile. Thin or absent review records scored lower.
Refund / Replacement Clarity (10 pts)
Dedicated policy page, clear window (30+ days), stated conditions, and a clear return process. Subscription cancellation ease is noted where customer complaints document difficulty.
Verdict
The mushroom wellness market has a transparency problem, not an ingredient problem. Many brands make products that may well be harmless functional supplements. But without a public COA, named species and format, and claims that stay within DSHEA bounds, a consumer has no basis for an informed decision. The ten questions in the consumer checklist below are the minimum a product page should answer — in under 90 seconds, without contacting the company. Most audited pages don't.
Consumer checklist
10 questions any product page should answer — before you buy
- 1What type of product is this — functional supplement, Amanita/muscimol, or psilocybin-adjacent?
- 2What mushroom species is used — named, not "mushroom blend"?
- 3Is it fruiting body or mycelium, and is the format stated?
- 4Is lab testing batch-specific, from a named accredited third-party lab?
- 5Can I access the COA before buying — no login, no purchase required?
- 6Does the page avoid disease-treatment claims?
- 7Are safety cautions visible — age, interactions, pregnancy?
- 8Is legal language careful — no "100% legal everywhere"?
- 9Is the company identifiable and reachable with a named contact?
- 10Can I understand all of this in under 90 seconds, without searching elsewhere?
Common questions
Answered directly
Is this report a product endorsement?
No. The report evaluates transparency only — what information a product page makes available to a consumer before purchase. No products are recommended, endorsed, or ranked for quality or clinical value. A high score means the information is present and accessible; it does not certify the product is safe or effective for any individual.
What is the 100-Point Transparency Score?
A scoring framework across ten dimensions: COA visibility, lab panel clarity, ingredient transparency, dosage clarity, medical claim restraint, legal disclaimers, support availability, shipping transparency, review visibility, and refund/replacement clarity. Maximum: 100 points. Scores reflect publicly visible information only — no products were purchased or independently laboratory tested.
Does a high score mean a product is safe or effective?
No. Transparency measures how clearly a company communicates. A transparent product page can still carry risks. The score identifies what information is present or absent — not whether a product is appropriate for any individual. Safety and efficacy require clinical evaluation, which this report does not provide.
Why is iMicrodosing.com included?
iMicrodosing.com is the eCommerce arm of the cluster that publishes this report. Excluding it would itself be a form of bias. It was scored on the full 100-point standard rubric with no adjustments and no N/A dimensions. iMicrodosing.com scored 80/100 Grade B — highest in the psilocybin-adjacent category across all 101 audited entries.
iMicrodosing fulfillment portal
Product-format context, policies, and fulfillment information live on the commerce property.
This .net page is the quick-reference layer. For deeper educational context, use iMicrodosing.org. For product-format and fulfillment context only, use the iMicrodosing.com portal.
Product-format context
For product-format context, policy details, and fulfillment information, see the iMicrodosing fulfillment portal. Keep the .net page as the 90-second reference layer and use .org for the full research layer.
Educational information only. Not medical advice. 21+ only.